Baga, Jemilyn O.
HRN: 28-34-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/06/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/06/2026
01/13/2026
IV
4.5g
Q8h
Uti Complicated
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes